Key facts
- TAS Medical’s last known valuation is $25.5M (Apr 2026).
- It has raised $16.5M across 3 recorded rounds; the latest was Seed Round ($3.9M) in Mar 2026.
- TAS Medical has filed 4 Form Ds with the SEC since 2024, most recently Apr 2026 ($3.9M sold to 17 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for TAS Medical
Funding rounds
3 roundsAbout TAS Medical
Developer of a transabdominal strap designed to assist in abdominal closures and ventral hernia repairs while performing abdominal surgeries. The company's strap facilitates reproducible precision and full-thickness closures to convert ventral hernia procedures to minimally invasive surgery while eliminating the need for mesh in these procedures, enabling surgeons to improve hernia recurrence rates, healthcare economics, and quality of life outcomes.
- Sector
- Healthcare
- HQ
- Windermere, FL, United States
- Founded
- 2017
- Employees
- 9
- Website
- tasmedical.net/
- Ownership
- Privately Held (backing)
TAS Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TAS Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TAS Medical in its N-PORT filings yet. We sweep new filings monthly.